2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.

Industry wonders how emergency agency's COVID-19 public-private partnerships will fit in with the others.

AmerisourceBergen, McKesson, Cardinal and others can help FEMA deliver hydroxychloroquine and manage critical-drugs supply chain without running afoul of federal antitrust law.

Medical supplies manufacturers can collaborate to address the novel coronavirus pandemic without violating antitrust law, the US Department of Justice has said.